SP Ventures Exits Brazilian Biotech Firm Bug with Sale to Koppert (em português)

December 18, 2017

SP Ventures Bug Agentes Biológicos LAVCA

SP Ventures exited Bug Agentes Biológicos, a Brazilian biotech firm, though a sale to Dutch biochemical company Koppert Biological Systems.

(Valor Econômico) A holandesa Koppert fechou a aquisição, por meio de sua subsidiária brasileira, da Bug Agentes Biológicos, com sede em Piracicaba. Com a aquisição da empresa de controle biológico, cujo valor não foi divulgado, a Koppert afirma chegar ao primeiro lugar no ranking do setor na América Latina.

Tweets

"According to LAVCA Data, VC investment into Latin American fintech totaled USD1.2b in the first quarter of 2022."… https://t.co/oikd3BXiCU

24-Jun-2022

Reply Retweet Favorite
Felicitaciones a la Directora Ejecutiva de LAVCA @lavca_org Ángela María Tafur @naitafur quien se ha incorporado al… https://t.co/qjHgnmFPS3

14-Jun-2022

Reply Retweet Favorite
LAVCA's Director of Venture Capital @crdelavega_ shares insights with @TechCrunch's @bayareawriter on the latest d… https://t.co/krypDTI5NE

14-Jun-2022

Reply Retweet Favorite
Congratulations to LAVCA's Executive Director @naitafur who has joined the Board of Directors of @GRUPOSURA. https://t.co/47bv5fyVhT

13-Jun-2022

Reply Retweet Favorite
In 2018, @_AquaCapital invested in agricultural biologicals platform @Biotropbr. In 3 years, the company has reduce… https://t.co/PDu5zkchTs

13-Jun-2022

Reply Retweet Favorite

Keep in touch

Twitter Linkedin Youtube

About LAVCA

LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

LAVCA Office

    New York City:
    589 8th Ave, 18th Floor
    New York, NY 10018

Explore LAVCA.org

About LAVCA
Board, Team, & Advisors
Media
Contact Us
Membership Benefits
Members Only Access
Education and Programs
Research
Policy
LAVCA VC